The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...
78.1% of Confluent shares are owned by institutional investors. 18.0% of Oncology Pharma shares are owned by insiders. Comparatively, 13.8% of Confluent shares are owned by insiders. Strong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback